levofloxacin has been researched along with Moraxella Infections in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujisaki, S; Kashiwa, M; Muto, S; Saito, R; Tamamori, Y; Yamada, K | 1 |
Gehanno, P; Pessey, JJ; Serrano, E | 1 |
Ambrose, PG; Anon, JB; Jones, RN; Kahn, JB; Paglia, M; Xiang, J | 1 |
2 trial(s) available for levofloxacin and Moraxella Infections
Article | Year |
---|---|
[Levofloxacin in the treatment of acute and bacteriologically documented sinusitis with high risk of complications].
Topics: Acute Disease; Adolescent; Adult; Africa, Southern; Aged; Bacterial Infections; Female; France; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Ofloxacin; Pneumococcal Infections; Prospective Studies; Risk; Sinusitis; Staphylococcal Infections; Treatment Outcome; Tunisia | 2005 |
Serial sinus aspirate samples during high-dose, short-course levofloxacin treatment of acute maxillary sinusitis.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Catheters, Indwelling; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Levofloxacin; Male; Maxillary Sinusitis; Microbial Sensitivity Tests; Middle Aged; Moraxella catarrhalis; Moraxellaceae Infections; Ofloxacin; Pneumococcal Infections; Streptococcus pneumoniae; Time Factors; Treatment Outcome | 2007 |
1 other study(ies) available for levofloxacin and Moraxella Infections
Article | Year |
---|---|
Molecular Characterization of Fluoroquinolone-Resistant Moraxella catarrhalis Variants Generated
Topics: Anti-Bacterial Agents; Base Sequence; DNA Gyrase; DNA Topoisomerase IV; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Moraxellaceae Infections; Mutation; Respiratory Tract Infections; Selection, Genetic; Sequence Analysis, DNA; Topoisomerase Inhibitors | 2017 |